KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Cash from Financing Activities (2018 - 2026)

Castle Biosciences' Cash from Financing Activities history spans 8 years, with the latest figure at -$4.6 million for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 14.78% to -$4.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$7.0 million, a 213.37% decrease, with the full-year FY2025 number at -$7.0 million, down 213.37% from a year prior.
  • Cash from Financing Activities hit -$4.6 million in Q4 2025 for Castle Biosciences, down from -$919000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for CSTL hit a ceiling of $10.6 million in Q1 2024 and a floor of -$5.4 million in Q4 2024.
  • Historically, Cash from Financing Activities has averaged $190850.0 across 5 years, with a median of $176000.0 in 2021.
  • Biggest five-year swings in Cash from Financing Activities: plummeted 695.24% in 2022 and later surged 1762.22% in 2024.
  • Tracing CSTL's Cash from Financing Activities over 5 years: stood at $126000.0 in 2021, then plummeted by 695.24% to -$750000.0 in 2022, then crashed by 339.6% to -$3.3 million in 2023, then tumbled by 63.33% to -$5.4 million in 2024, then grew by 14.78% to -$4.6 million in 2025.
  • Business Quant data shows Cash from Financing Activities for CSTL at -$4.6 million in Q4 2025, -$919000.0 in Q3 2025, and $101000.0 in Q2 2025.